The threonine protease activity of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Li, Yu Yin ^a   Bao, Yong Li ^a   Song, Zhen Bo ^a   Sun, Lu Guo ^a   Wu, Ping ^a   Zhang, Yu ^a   Fan, Cong ^a   Huang, Yan Xin ^a   Wu, Yin ^a   Yu, Chun Lei ^a   Sun, Ying ^a   Zheng, Li Hua ^a   Wang, Guan Nan ^a   Li, Yu Xin ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; PROTEINASE; TESTES SPECIFIC PROTEASE 50; THREONINE; THREONINE 310; THREONINE PROTEINASE; UNCLASSIFIED DRUG; DOXORUBICIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE PROTEINASE; TESTIS SPECIFIC PROTEASE 50; TESTIS-SPECIFIC PROTEASE 50;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; ALLELE; ANIMAL; CELL STRAIN HEK293; CHEMICAL STRUCTURE; CHEMISTRY; CHO CELL; CRICETULUS; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVE SITE; GENETICS; HAMSTER; METABOLISM; NEOPLASM; PATHOLOGY; POINT MUTATION; SIGNAL TRANSDUCTION;

CRICETULUS GRISEUS; MUS MUSCULUS;

ALLELES; ANIMALS; APOPTOSIS; CATALYTIC DOMAIN; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; MICE; MODELS, MOLECULAR; NEOPLASMS; NF-KAPPA B; POINT MUTATION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; THREONINE;

EID: 84860521722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035030     Document Type: Article

References (40)

1. Yuan L, Shan J, De Risi D, Broome J, Lovecchio J, et al. (1999) Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer. Cancer Res 59: 3215-3221.
2. Shan J, Yuan L, Xiao Q, Chiorazzi N, Budman D, et al. (2002) TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Res 62: 290-294.
3. Xu HP, Yuan L, Shan J, Feng H, (2004) Localization and expression of TSP50 protein in human and rodent testes. Urology 64: 826-832.
4. Zheng L, Xie G, Duan G, Yan X, Li Q, (2011) High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma. PLoS One 6: e22203.
5. Zhou L, Bao YL, Zhang Y, Wu Y, Yu CL, et al. (2010) Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells. IUBMB Life 62: 825-832.
6. Song Z, Bao Y, Zhang Y, Mi X, Wu P, et al. (2011) Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the NF-kappa beta (NF-kappaB) signaling pathway. Biochem J 436 (2): 457-467.
7. Hedstrom L, (2002) An overview of serine proteases. Curr Protoc Protein Sci Chapter 21: Unit 21 10.
8. Page MJ, Di Cera E, (2008) Evolution of peptidase diversity. J Biol Chem 283: 30010-30014.
9. Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP, (2004) Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochim Biophys Acta 1698: 77-86.
10. Wlodawer A, Li M, Gustchina A, Oyama H, Dunn BM, et al. (2003) Structural and enzymatic properties of the sedolisin family of serine-carboxyl peptidases. Acta Biochim Pol 50: 81-102.
11. Xu H, Shan J, Jurukovski V, Yuan L, Li J, et al. (2007) TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Res 67: 1239-1245.
12. Hamburger AW, Salmon SE, (1977) Primary bioassay of human tumor stem cells. Science 197: 461-463.
13. Thomson SP, Meyskens FL Jr, (1982) Method for measurement of self-renewal capacity of clonogenic cells from biopsies of metastatic human malignant melanoma. Cancer Res 42: 4606-4613.
14. Buick RN, MacKillop WJ, (1981) Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma. Br J Cancer 44: 349-355.
15. Schreiner C, Fisher M, Hussein S, Juliano RL, (1991) Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res 51: 1738-1740.
16. Fiore M, Degrassi F, (1999) Dimethyl sulfoxide restores contact inhibition-induced growth arrest and inhibits cell density-dependent apoptosis in hamster cells. Exp Cell Res 251: 102-110.
17. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, et al. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem 279: 25535-25543.
18. Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, et al. (2002) Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234-235: 119-124.
19. Hayden MS, Ghosh S, (2011) NF-kappaB in immunobiology. Cell Res 21: 223-244.
20. Majdalawieh A, Ro HS, (2010) Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm 2010 823821.
21. Zheng C, Yin Q, Wu H, (2011) Structural studies of NF-kappaB signaling. Cell Res 21: 183-195.
22. Karin M, Greten FR, (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
23. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
24. de Visser KE, Eichten A, Coussens LM, (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37.
25. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
26. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
27. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
28. Nelsen B, Hellman L, Sen R, (1988) The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol Cell Biol 8: 3526-3531.
29. Cheng HC, Abdel-Ghany M, Elble RC, Pauli BU, (1998) Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 273: 24207-24215.
30. Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK, et al. (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62: 4767-4772.
31. Duffy MJ, (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10: 39-49.
32. Picard V, Ersdal-Badju E, Lu A, Bock SC, (1994) A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res 22: 2587-2591.
33. Jing Z, Ming Y, Ze-Li X, Yong-li B, Yin W, et al. (2006) Preparation of Polyclonal Antibodies Against Testis-specific Protease 50 and Characterization of Antibody Specificity. CHEM RES CHINESE U 22: 308-311.
34. Zhang Y, (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40.
35. Zhang Y, (2009) I-TASSER: fully automated protein structure prediction in CASP8. Proteins 77 (Suppl 9): 100-113.
36. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725-738.
37. Cui H, Ma J, Ding J, Li T, Alam G, et al. (2006) Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 281: 34696-34704.
38. McLemore TL, Eggleston JC, Shoemaker RH, Abbott BJ, Bohlman ME, et al. (1988) Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res 48: 2880-2886.
39. Jensen MM, Jorgensen JT, Binderup T, Kjaer A, (2008) Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med Imaging 8: 16.
40. Ansari KM, Rundhaug JE, Fischer SM, (2008) Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation. Mol Cancer Res 6: 1003-1016.